Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer

被引：0
|
作者：
Laura Mezquita
Marianne Oulhen
Agathe Aberlenc
Marc Deloger
Mihaela Aldea
Aurélie Honore
Yann Lecluse
Karen Howarth
Luc Friboulet
Benjamin Besse
David Planchard
Françoise Farace
机构：
[1] Gustave Roussy,
[2] Université Paris-Saclay,undefined
[3] Department of Medicine,undefined
[4] Medical Oncology Department,undefined
[5] Hospital Clinic of Barcelona,undefined
[6] Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors,undefined
[7] IDIBAPS,undefined
[8] Gustave Roussy,undefined
[9] Université Paris-Saclay,undefined
[10] “Rare Circulating Cells” Translational Platform,undefined
[11] CNRS UMS3655—INSERM US23 AMMICA,undefined
[12] INSERM,undefined
[13] U981 “Identification of Molecular Predictors and new Targets for Cancer Treatment”,undefined
[14] Gustave Roussy,undefined
[15] Université Paris-Saclay,undefined
[16] Bioinformatics Platform,undefined
[17] CNRS UMS3655—INSERM US23 AMMICA,undefined
[18] Gustave Roussy,undefined
[19] Université Paris-Saclay,undefined
[20] Genomic Platform,undefined
[21] CNRS UMS3655—INSERM US23 AMMICA,undefined
[22] Gustave Roussy,undefined
[23] Université Paris-Saclay,undefined
[24] “Flow cytometry and Imaging” Platform,undefined
[25] CNRS UMS3655—INSERM US23AMMICA,undefined
[26] Inivata Ltd,undefined
[27] Babraham Research Park,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：682 / 693
页数：11
相关论文
共 50 条
  • [31] BRAF Inhibitors in Non-Small Cell Lung Cancer
    Sforza, Vincenzo
    Palumbo, Giuliano
    Cascetta, Priscilla
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Damiano, Simona
    Forte, Cira Antonietta
    Frosini, Giulia
    Farese, Stefano
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2022, 14 (19)
  • [32] Targeting BRAF Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small-Cell Lung Cancer
    Aboubakar Nana, Frank
    Ocak, Sebahat
    PHARMACEUTICS, 2021, 13 (09)
  • [33] BRAF inhibitors in advanced BRAF-positive non-small cell lung cancer
    Vavala, Tiziana
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1323 - S1327
  • [34] Clinicopathological and Molecular Characteristics of Non-Small Cell Lung Cancer with BRAF Mutation
    Wang, Yue
    Li, Yuan
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1965 - S1967
  • [35] Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
    Li, Hui
    Zhang, Yongchang
    Xu, Yanjun
    Huang, Zhiyu
    Cheng, Guoping
    Xie, Mingyin
    Zhou, Zichao
    Yu, Yangyang
    Xi, Wenjing
    Fan, Yun
    CELL DEATH & DISEASE, 2022, 13 (12)
  • [36] Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation
    Ding, Xi
    Zhang, Zengli
    Jiang, Tao
    Li, Xuefei
    Zhao, Chao
    Su, Bo
    Zhou, Caicun
    CANCER MEDICINE, 2017, 6 (03): : 555 - 562
  • [37] Salinomycin, an anti-cancer stem cell antibiotic, overcomes acquired resistance to BRAF inhibitors in BRAF-mutant human melanoma cell lines.
    Crespo, Daniel
    Pulido, Ines
    Rodriguez, Maria L.
    Aparisi, Salvador
    Lopez, Alejandro
    Soucheray, Margaret
    Al-Shahrour, Fatima
    Shimamura, Takeshi
    Ortega, Angel
    Carretero, Julian
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations
    Marchetti, Antonio
    Felicioni, Lara
    Malatesta, Sara
    Sciarrotta, Maria Grazia
    Guetti, Luigi
    Chella, Antonio
    Viola, Patrizia
    Pullara, Carmela
    Mucilli, Felice
    Buttitta, Fiamma
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3574 - 3579
  • [39] Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
    Hui Li
    Yongchang Zhang
    Yanjun Xu
    Zhiyu Huang
    Guoping Cheng
    Mingyin Xie
    Zichao Zhou
    Yangyang Yu
    Wenjing Xi
    Yun Fan
    Cell Death & Disease, 13
  • [40] Genomic profiling for advanced non-small-cell lung cancer (NSCLC) from circulating tumour DNA (ctDNA)
    Loong, H.
    Raymond, V.
    Chua, D. T. T.
    Teo, P. M. L.
    Yung, T.
    Lanman, R. B.
    Skrzypczak, S.
    Mok, T. S. K.
    ANNALS OF ONCOLOGY, 2017, 28 : 173 - 173
12345